Democratizing Advanced Fertility

NAYA Fertility, formed through the merger of NAYA Biosciences and INVO Bioscience, aims to address rapidly expanding demand and limited accessibility in the fertility market.

INVOcell® is our novel, FDA-cleared IVC device. It offers a viable alternative to IVF that uses the female body for fertilization and incubation, keeping women at the center of the reproductive process. This unique method allows us to reduce costs, increase accessibility, and improve the patient experience.



















NAYA Fertility aims to expand INVO's acquisition and expansion strategy through both fully-owned and affiliated clinics offering its INVOcell-enabled IVC procedures as well as traditional IVF. INVO has recently acquired the Wisconsin Fertility Institute.